Xilio Therapeutics, Inc. (XLO) Social Stream
XILIO THERAPEUTICS INC (XLO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering XILIO THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-12 | 5 | $40 | $31 | $34.75 | $2.98 | 1066.11% |
| 2022-08-09 | 4 | $40 | $31 | $34.333 | $2.98 | 1052.11% |
| 2022-08-10 | 4 | $40 | $20 | $30.333 | $2.98 | 917.89% |
| 2022-11-10 | 4 | $20 | $13 | $16.5 | $2.98 | 453.69% |
| 2022-12-21 | 4 | $20 | $7 | $13.333 | $2.98 | 347.42% |
| 2023-05-10 | 4 | $13 | $7 | $10 | $2.98 | 235.57% |
| NA | 3 | $NA | $NA | $NA | $2.98 | NA% |
The Trend in the Analyst Price Target
XLO's average price target has moved down $0 over the prior 103 days.
XLO reports an average of 584.68% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-10 | 4 | 40 | 20 | 30.333 | 2.47 | 1128.06% |
| 2022-11-10 | 4 | 20 | 13 | 16.500 | 2.44 | 576.23% |
| 2022-11-10 | 3 | 40 | 13 | 24.333 | 2.44 | 897.25% |
| 2022-11-10 | 4 | 40 | 13 | 24.333 | 2.44 | 897.25% |
| 2023-05-10 | 4 | 13 | 7 | 10.000 | 3.20 | 212.5% |
XLO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
XLO's average broker recommendation rating improved by 0.15 over the prior 14 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XLO as an investment opportunity.
- XILIO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 750.33% of all US stocks.
- In the context of all US stocks, XILIO THERAPEUTICS INC's number of analysts covering the stock is higher than 130.59% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, XILIO THERAPEUTICS INC's variance in analysts' estimates is lower than -215.2% of them.
- XLO has a higher average analyst price target than 445.12% of stocks in the small market cap category.
Stocks similar to XILIO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LIAN, BWV, and ANTX.
View All Top Stocks by Price Target
Is XLO a Buy, Hold or Sell? See the POWR Ratings now!